Genetic Technologies(GENE) - 2023 Q2 - Earnings Call Transcript
Genetic Technologies(GENE)2023-02-28 00:56Adrian Mulcahy - Investor Relations Carl Stubbings - Chief Commercial Officer Â…for those in the US that are joining us this morning and this afternoon for Genetic Technologies First Half FY '23 Investor Webinar. With us today are Simon Morriss, CEO, Tony Di Pietro, the CFO and Carl Stubbings, the Chief Commercial Officer. Simon Morriss We operate three brands across the world. Our GeneType brands to serious disease, EasyDNA and AffinityDNA for a more consumer-based genomic test across Europe, America and S ...